Variability of 7K and 11K SomaScan Plasma Proteomics Assays
Level 5 - mechanism / opinion, no new human data
Bench/technical assay validation study without clinical endpoints (graded by design analogy, not clinical CEBM).
OpenAlex W4403900624 · doi:10.1021/acs.jproteome.4c00667
What was done
The authors evaluated the technical precision and reproducibility of aptamer-based SomaScan plasma proteomics platforms using technical replicates from donors enrolled in the Baltimore Longitudinal Study of Aging. They analyzed a second batch of technical replicates on the 7K SomaScan assay alongside intraplate and interplate replicate measurements on the expanded 11K assay using the same donor samples. The study estimated interbatch variability, assessed intra- and interplate variability for the 11K assay, compared variability between the 7K and 11K versions using overlapping replicate pairs, and evaluated the impact of sample storage duration ranging from 2 to 30 years on assay precision.
What was found
The abstract reports no numerical data, coefficients of variation, correlation coefficients, or statistical estimates regarding the observed platform variability, assay concordance, or storage duration effects.
Why it matters
As large-scale biomarker and epidemiological studies transition between SomaScan assay generations, technical benchmarking of batch effects, platform concordance, and storage stability is essential for accurate study design and cross-batch data normalization.
Limits
The abstract does not disclose any quantitative metrics to assess the magnitude of variability or precision. The total number of donors, samples, and technical replicates is not stated. The analysis is limited to technical precision and replicate concordance, without evaluating biological validity, aptamer binding specificity, or cross-reactivity.
Cited by
- supports Modern proteomic platforms can measure the concentrations of up to 11,000 proteins from a single drop of blood.